Skin Diseases, Infectious

Search with Google Search with Bing
Information
Disease name
Skin Diseases, Infectious
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05608382 Completed N/A Effect of an Antiseptic Solution on the Skin Microbiome March 7, 2022 March 18, 2022
NCT00210899 Completed Phase 3 Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections September 2005 October 2006
NCT00228410 Completed Phase 3 Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections November 2002 December 2003
NCT00228982 Completed Phase 3 Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections October 2004 December 2005
NCT00257036 Completed Phase 2/Phase 3 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin July 1991 February 1993
NCT00257062 Completed Phase 3 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin January 1993 April 1994
NCT00343135 Completed Phase 4 AUGMENTIN 1gm In Skin And Soft Tissue Infection December 2004 March 2005
NCT00388310 Completed N/A Effective Antibiotic Treatment of MRSA February 2006 December 2008
NCT03981822 Completed Phase 2 A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts June 25, 2019 July 8, 2020
NCT04485676 Completed Dalbavancin in Real Clinical Practice in Spain July 15, 2020 February 21, 2021
NCT00198679 Completed Phase 4 Effect of Chlorhexidine Skin Cleansing on Skin Flora March 2004 March 2005
NCT00488345 Completed Phase 2 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age December 2007 September 2009
NCT00488761 Completed Phase 4 Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI July 2006 August 2007
NCT00679302 Completed Phase 4 Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management July 2006 May 2008
NCT00711802 Completed Phase 4 Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections July 23, 2008 October 11, 2013
NCT00746109 Completed Phase 4 Study of Wound Packing After Superficial Skin Abscess Drainage September 2008 March 2010
NCT00761215 Completed Phase 2 Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections September 17, 2008 February 24, 2009
NCT00785200 Completed N/A MRSA Colonization and Control in the Dallas County Jail January 2009 February 2010
NCT01967225 Completed Phase 3 Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections November 23, 2013 October 28, 2016
NCT02276482 Completed Phase 3 Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) March 25, 2015 September 17, 2018
NCT02582203 Completed Phase 4 Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA February 2012 May 2016
NCT02600871 Completed Phase 4 Skin and Soft Tissue Infection (SSTI) Study December 2015 May 30, 2017
NCT03487549 Completed Phase 2 Cantharidin and Occlusion in Verruca Epithelium March 27, 2018 July 15, 2019
NCT03643952 Completed Phase 2 Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) December 6, 2018 April 7, 2020
NCT00430937 Terminated Phase 3 Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections April 2006
NCT00865280 Terminated Phase 3 Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) April 4, 2009 April 15, 2010
NCT00990392 Withdrawn N/A Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections November 2009 January 2011
MeSH unique ID (MeSH (Medical Subject Headings))
D012874